Your new experience awaits. Try the new design now and help us make it even better

SYSTEMATIC REVIEW article

Front. Pharmacol.

Sec. Drugs Outcomes Research and Policies

Volume 16 - 2025 | doi: 10.3389/fphar.2025.1568696

This article is part of the Research TopicEnvironmental Impact of MedicinesView all 3 articles

Facilitators for Establishing a Home-based Medicine Reverse Logistic Systems in Low-and Middle-Income Countries -A Scoping Review

Provisionally accepted
  • 1Amala Institute of Medical Sciences, Thrissur, India
  • 2Kerala One Health Centre for Nipah Research and Resilience,, Kozhikode., India

The final, formatted version of the article will be published soon.

Background: The end-of-use and end-of-life medicines at households are often disposed of improperly, which has harmful environmental impacts. Health hazards like antimicrobial resistance can occur. A home/household-based medicine reverse logistics system can avoid improper disposal of medicine waste, and it can recover any remaining value from end-of-use medicines.Methods-We did a scoping review to identify the key facilitators that help the initiation and establishment of a Medicine Reverse Logistics (MRL) system for the collection of unused medicines from households. Google Scholar and PubMed were the databases searched. A qualitative synthesis of included studies was performed. Themes and subthemes were identified. The keywords used were medicines, drugs, reverse logistics, homes, houses, and households.Results-The awareness level of the various stakeholders, the sharing of responsibilities among stakeholders, incentives to stakeholders, political will and legal framework, and the utilization of logistics managerial capabilities of pharmaceutical companies were identified as key facilitators.

Keywords: Medicines, drugs, Drug waste, Reverse logistic chain, environmental risk

Received: 30 Jan 2025; Accepted: 07 Jul 2025.

Copyright: © 2025 Vincent and Thekkumkara. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Jose Vincent, Amala Institute of Medical Sciences, Thrissur, India

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.